Valuation: Norda ASA

Market Cap 513M 54.44M 47.48M 44.83M 40.71M 76.27M 5.22B 76.59M 537M 207M 2.66B 205M 200M 8.55B P/E 2023 *
-
P/E 2024 3.26x
Enterprise Value 264M 28.05M 24.46M 23.09M 20.97M 39.29M 2.69B 39.45M 277M 107M 1.37B 105M 103M 4.4B EV / Sales 2023
-1.24x
EV / Sales 2024 0.4x
Free-Float
6.26%
Yield 2023 *
-
Yield 2024 32.5%
1 day-0.46%
1 week+1.06%
Current month+1.18%
1 month-0.46%
3 months-0.46%
6 months+1.06%
Current year-14.00%
1 week 86
Extreme 86
86.4
1 month 85
Extreme 85
86.4
Current year 81
Extreme 81
86.4
1 year 81
Extreme 81
100
3 years 41
Extreme 41
100
5 years 41
Extreme 41
100
10 years 8
Extreme 8
100
Manager TitleAgeSince
Chief Executive Officer - 08/04/2013
Director TitleAgeSince
Chairman 54 31/01/2014
Director/Board Member 68 20/06/2013
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-0.46%+1.06%+6.17%+109.76% 46.86M
+0.11%+1.98%-0.04%+9.69% 46.18B
-1.12%+3.54%+42.71%+25.84% 44.35B
-3.04%-6.10%+335.86%+501.23% 42.21B
-0.74%+2.64%+5.61%+75.14% 40.19B
-0.50%-0.77%+11.86%+40.41% 29.83B
-0.46%+5.00%+23.00%+118.70% 17.17B
-0.97%-9.38% - - 15.7B
-0.57%+7.78%+21.76%+38.08% 15.32B
-3.28%-0.95%-6.34%-37.29% 13.09B
Average -1.11%+1.45%+48.96%+97.95% 26.41B
Weighted average by Cap. -1.12%+1.63%+69.63%+117.22%

Financials

2023 2024
Net sales 86.92M 9.22M 8.04M 7.59M 6.89M 12.92M 885M 12.97M 90.95M 35.1M 450M 34.64M 33.87M 1.45B 372M 39.45M 34.4M 32.48M 29.5M 55.27M 3.79B 55.5M 389M 150M 1.92B 148M 145M 6.19B
Net income 31.17M 3.31M 2.88M 2.72M 2.47M 4.63M 317M 4.65M 32.62M 12.59M 161M 12.42M 12.15M 519M 126M 13.36M 11.65M 11M 9.99M 18.72M 1.28B 18.8M 132M 50.86M 652M 50.19M 49.08M 2.1B
Net Debt -311M -33.02M -28.79M -27.19M -24.69M -46.26M -3.17B -46.45M -326M -126M -1.61B -124M -121M -5.18B -249M -26.4M -23.02M -21.74M -19.74M -36.98M -2.53B -37.13M -260M -100M -1.29B -99.16M -96.96M -4.14B
Logo Norda ASA
Norda ASA, formerly NorDiag ASA, is a Norway-based company active within the biotechnology sector. It develops, manufactures and markets automated solutions (instruments and tests) for sample preparation of bacterial and human DNA from difficult biological samples for use in the fields of infectious diseases, transplantation testing (HLA Typing) and others. The Company’s products include NorDiag Arrow (CE, IVD), which is a compact, automated solution for nucleic acid extractions, as well as NorDiag Bullet, 8 tip config, which is a fully automated sample preparation instrument for molecular diagnostics and can isolate from samples such as urine, swab, faces, sputum and blood. Its distribution products include Molzym GmbH and Co KG, as well as Hain Lifescience GmbH. Its customers are clinical laboratories, hospitals, research institutes, medical diagnostics and healthcare providers. It is operational through offices and laboratories in Norway, Sweden, Austria and the United States.
Employees
1
Date Price Change Volume
16/09/26 NOK 86.00 -0.46% 40
  1. Stock Market
  2. Stocks
  3. NORD Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!